Both analyses, thus, demonstrate that the combined presence of BRCA1/2 mutations and low FMR1 alleles actually appears to be less commonly associated with ovarian cancer than absence of both of these mutations in the same patient. The gene discussed is BRCA1; the disease is ovarian cancer.